Effect of polypharmacy on plasma bepridil concentration in patients with heart failure: a multicenter retrospective study
Abstract Background Polypharmacy, defined as the concurrent use of over six drugs, is common in the treatment of heart failure (HF); however, unpredictable drug interactions with bepridil may occur. In this study, we have elucidated the influence of polypharmacy on plasma bepridil concentrations in...
Saved in:
Main Authors: | Yuki Asai (Author), Hiroki Arihara (Author), Saki Omote (Author), Ena Tanio (Author), Saena Yamashita (Author), Takashi Higuchi (Author), Ei Hashimoto (Author), Momoko Yamada (Author), Hinako Tsuji (Author), Yoshihiro Kondo (Author), Makoto Hayashi (Author), Yoshiaki Yamamoto (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of microminipig as a laboratory animal for pharmacological study by analyzing bepridil-induced cardiovascular responses
by: Yoshio Nunoi, et al.
Published: (2020) -
Bepridil Facilitates Early Termination of Spiral-Wave Reentry in Two-Dimensional Cardiac Muscle Through an Increase of Intercellular Electrical Coupling
by: Hiroki Takanari, et al.
Published: (2011) -
Impact of polypharmacy on 3-year mortality in patients with heart failure: a retrospective study
by: Daisuke Hayashi, et al.
Published: (2024) -
Pityriasis Lichenoides et Varioliformis Acuta Developing during Pembrolizumab Treatment for Bladder Cancer
by: Yuki Mizutani, et al.
Published: (2024) -
POLYPHARMACY: RESPONSE
by: S. O. Kluchnikov
Published: (2015)